Influence of HLA-DP supertype on the survival of childhood acute lymphoblastic leukaemia: analysis of the UKALL X1 trial

Influence of HLA-DP supertype on the survival of childhood acute lymphoblastic leukaemia: analysis of the UKALL X1 trial

Dades bibliogràfiques
Autors principals:	Taylor, G, Richards, S, Hussain, A, Simpson, J, Eden, T
Format:	Conference item
Publicat:	2008

Ítems similars

No association of HLA-A supertype with outcome in childhood acute lymphoblastic leukaemia: results of the UKALL XI trial.
per: Thompson, P, et al.
Publicat: (2011)

Relationship between HLA-DP supertype and survival in childhood acute lymphoblastic leukaemia: evidence for selective loss of immunological control of residual disease?
per: Taylor, G, et al.
Publicat: (2009)

HLA-DPβ1 Asp84-Lys69 antigen-binding signature predicts event-free survival in childhood B-cell precursor acute lymphoblastic leukaemia: results from the MRC UKALL XI childhood ALL trial.
per: Taylor, G, et al.
Publicat: (2012)

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
per: Chessells, J, et al.
Publicat: (1995)

Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
per: Chessels, J, et al.
Publicat: (1997)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
per: Chessells, J, et al.
Publicat: (1994)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience
per: Wheeler, K, et al.
Publicat: (1998)

UKALL XI randomised trial stratified CNS treatments and prospective neuropsychological assessment in childhood acute lymphoblastic leukaemia (ALL).
per: Hill, F, et al.
Publicat: (2000)

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.
per: Harrison, G, et al.
Publicat: (2000)

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
per: Chessells, J, et al.
Publicat: (1992)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
per: Chessells, J, et al.
Publicat: (1997)

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial
per: Harrison, G, et al.
Publicat: (2000)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.
per: Wheeler, K, et al.
Publicat: (1998)

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
per: Chessells, J, et al.
Publicat: (1995)

Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
per: Wheeler, K, et al.
Publicat: (1996)

Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI).
per: Hargrave, DR, et al.
Publicat: (2001)

Long survival in childhood lymphoblastic leukaemia.
per: Chessells, J, et al.
Publicat: (1987)

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
per: Eden, O, et al.
Publicat: (1991)

Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
per: Chessells, J, et al.
Publicat: (1986)

High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis.
per: Patel, B, et al.
Publicat: (2008)

Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
per: Richards, S, et al.
Publicat: (1998)

Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
per: Chessells, J, et al.
Publicat: (2002)

Late relapsing childhood acute lymphoblastic leukaemia.
per: Frost, L, et al.
Publicat: (1998)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
per: Hann, I, et al.
Publicat: (2000)

Blast cell vacuoles in childhood lymphoblastic leukaemia.
per: Lilleyman, J, et al.
Publicat: (1988)

Late relapsing childhood lymphoblastic leukaemia.
per: Frost, L, et al.
Publicat: (1997)

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party.
per: Secker-Walker, L, et al.
Publicat: (1997)

Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
per: Durrant, I, et al.
Publicat: (1993)

The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI.
per: Halsey, C, et al.
Publicat: (2011)

The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI
per: Vargha-Khadem Faraneh, et al.
Publicat: (2011-10-01)

The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties.
per: Chessells, J, et al.
Publicat: (1998)

Improved survival with early intensification: combined results from the Medical Research Council Childhood ALL randomised trials, UKALL X and UKALL XI
per: Richards, S, et al.
Publicat: (1998)

Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods.
per: Eden, O, et al.
Publicat: (1990)

PROSPECTIVE EVALUATION OF QUALITY OF LIFE (QOL) IN CHILDREN TREATED IN UKALL 2003 FOR ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL): A COHORT STUDY
per: Eiser, C, et al.
Publicat: (2012)

HLA-Haploidentical Family Donors: The New Promise for Childhood Acute Lymphoblastic Leukaemia?
per: Syaza Ab Rahman, et al.
Publicat: (2022-01-01)

Treatment-related Complications in Childhood Acute Lymphoblastic Leukemia: Results of Medical Research Council UKALL X
per: Ehsan Shahverdi, et al.
Publicat: (2020-04-01)

Intraocular relapse of childhood acute lymphoblastic leukaemia.
per: Somervaille, T, et al.
Publicat: (2003)

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
per: Sive, J, et al.
Publicat: (2012)

Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia.
per: McLeod, H, et al.
Publicat: (1999)

Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults.
per: Durrant, I, et al.
Publicat: (1997)